Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| endothelial cell | 25 studies | 49% ± 18% | |
| astrocyte | 19 studies | 52% ± 19% | |
| oligodendrocyte | 16 studies | 72% ± 18% | |
| oligodendrocyte precursor cell | 14 studies | 55% ± 18% | |
| microglial cell | 14 studies | 49% ± 17% | |
| glutamatergic neuron | 13 studies | 69% ± 22% | |
| mast cell | 12 studies | 47% ± 19% | |
| GABAergic neuron | 11 studies | 69% ± 22% | |
| macrophage | 11 studies | 43% ± 18% | |
| fibroblast | 11 studies | 45% ± 11% | |
| smooth muscle cell | 11 studies | 39% ± 15% | |
| pericyte | 10 studies | 42% ± 16% | |
| adipocyte | 9 studies | 57% ± 13% | |
| mesothelial cell | 8 studies | 41% ± 14% | |
| epithelial cell | 7 studies | 45% ± 24% | |
| endothelial cell of lymphatic vessel | 7 studies | 37% ± 11% | |
| neuron | 6 studies | 65% ± 20% | |
| interneuron | 6 studies | 79% ± 13% | |
| cardiac muscle cell | 6 studies | 75% ± 18% | |
| basal cell | 6 studies | 48% ± 25% | |
| T cell | 5 studies | 26% ± 7% | |
| myeloid cell | 5 studies | 35% ± 14% | |
| type I pneumocyte | 5 studies | 54% ± 9% | |
| type II pneumocyte | 5 studies | 35% ± 7% | |
| granule cell | 4 studies | 65% ± 7% | |
| dendritic cell | 4 studies | 23% ± 3% | |
| endothelial cell of artery | 4 studies | 38% ± 16% | |
| vein endothelial cell | 4 studies | 35% ± 17% | |
| Mueller cell | 4 studies | 48% ± 16% | |
| amacrine cell | 4 studies | 63% ± 18% | |
| retina horizontal cell | 4 studies | 51% ± 21% | |
| retinal cone cell | 4 studies | 50% ± 14% | |
| retinal ganglion cell | 4 studies | 66% ± 21% | |
| retinal rod cell | 4 studies | 44% ± 10% | |
| ciliated cell | 4 studies | 34% ± 13% | |
| club cell | 4 studies | 39% ± 9% | |
| monocyte | 4 studies | 29% ± 9% | |
| cholangiocyte | 3 studies | 45% ± 17% | |
| differentiation-committed oligodendrocyte precursor | 3 studies | 59% ± 9% | |
| GABAergic interneuron | 3 studies | 77% ± 0% | |
| glial cell | 3 studies | 47% ± 12% | |
| progenitor cell | 3 studies | 49% ± 15% | |
| CD4-positive, alpha-beta T cell | 3 studies | 20% ± 3% | |
| GABAergic amacrine cell | 3 studies | 68% ± 17% | |
| OFF-bipolar cell | 3 studies | 47% ± 19% | |
| ON-bipolar cell | 3 studies | 49% ± 20% | |
| glycinergic amacrine cell | 3 studies | 58% ± 15% | |
| endothelial cell of vascular tree | 3 studies | 54% ± 16% | |
| hepatocyte | 3 studies | 51% ± 17% | |
| retinal pigment epithelial cell | 3 studies | 48% ± 29% | |
| ependymal cell | 3 studies | 58% ± 20% | |
| B cell | 3 studies | 23% ± 10% | |
| alveolar macrophage | 3 studies | 38% ± 6% | |
| capillary endothelial cell | 3 studies | 41% ± 13% | |
| respiratory goblet cell | 3 studies | 46% ± 16% | |
| muscle cell | 3 studies | 45% ± 31% | |
| mucus secreting cell | 3 studies | 43% ± 5% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| esophagus | 100% | 2906.91 | 1444 / 1445 | 100% | 20.80 | 183 / 183 |
| brain | 100% | 3898.49 | 2642 / 2642 | 100% | 21.61 | 703 / 705 |
| prostate | 100% | 2082.09 | 245 / 245 | 99% | 10.76 | 496 / 502 |
| breast | 100% | 2627.34 | 459 / 459 | 98% | 13.17 | 1101 / 1118 |
| skin | 100% | 5652.00 | 1808 / 1809 | 99% | 13.85 | 465 / 472 |
| bladder | 100% | 2825.33 | 21 / 21 | 97% | 12.97 | 491 / 504 |
| lung | 99% | 2136.61 | 575 / 578 | 98% | 13.60 | 1127 / 1155 |
| thymus | 100% | 1918.98 | 651 / 653 | 97% | 12.98 | 589 / 605 |
| uterus | 100% | 3018.17 | 170 / 170 | 97% | 15.35 | 444 / 459 |
| adrenal gland | 100% | 3773.84 | 258 / 258 | 96% | 11.48 | 221 / 230 |
| kidney | 100% | 1438.39 | 89 / 89 | 95% | 10.27 | 860 / 901 |
| stomach | 97% | 1520.34 | 350 / 359 | 94% | 7.26 | 270 / 286 |
| intestine | 100% | 2293.96 | 966 / 966 | 91% | 6.29 | 482 / 527 |
| ovary | 100% | 3201.95 | 180 / 180 | 80% | 4.90 | 345 / 430 |
| pancreas | 79% | 704.09 | 258 / 328 | 98% | 10.12 | 174 / 178 |
| adipose | 100% | 2825.22 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 2708.23 | 1335 / 1335 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 16.69 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 12.97 | 1 / 1 |
| spleen | 100% | 1156.37 | 240 / 241 | 0% | 0 | 0 / 0 |
| muscle | 99% | 1479.80 | 793 / 803 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 99% | 14.85 | 79 / 80 |
| heart | 99% | 5552.27 | 850 / 861 | 0% | 0 | 0 / 0 |
| liver | 45% | 343.62 | 101 / 226 | 52% | 3.43 | 211 / 406 |
| lymph node | 0% | 0 | 0 / 0 | 28% | 1.10 | 8 / 29 |
| peripheral blood | 7% | 51.11 | 61 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0090522 | Biological process | vesicle tethering involved in exocytosis |
| GO_0006904 | Biological process | vesicle docking involved in exocytosis |
| GO_0006886 | Biological process | intracellular protein transport |
| GO_0006887 | Biological process | exocytosis |
| GO_0000281 | Biological process | mitotic cytokinesis |
| GO_0006893 | Biological process | Golgi to plasma membrane transport |
| GO_0090148 | Biological process | membrane fission |
| GO_0000145 | Cellular component | exocyst |
| GO_0005515 | Molecular function | protein binding |
| Gene name | EXOC6B |
| Protein name | Exocyst complex component Exocyst complex component 6B (Exocyst complex component Sec15B) (SEC15-like protein 2) Exocyst complex component 6B |
| Synonyms | KIAA0919 SEC15B SEC15L2 |
| Description | FUNCTION: Component of the exocyst complex involved in the docking of exocytic vesicles with fusion sites on the plasma membrane. FUNCTION: Component of the exocyst complex involved in the docking of exocytic vesicles with fusion sites on the plasma membrane. . FUNCTION: Component of the exocyst complex involved in the docking of exocytic vesicles with fusion sites on the plasma membrane. . |
| Accessions | J3QT38 ENST00000272427.11 [Q9Y2D4-1] ENST00000410104.1 Q9Y2D4 A0A0U1RRB6 ENST00000410112.6 ENST00000634650.1 F8W6R7 |